InvestSMART

Cochlear Limited (ASX: COH) - ETF Exposure

Current share price for COH : $125.990 3.99 (3.27%)+

Cochlear Limited (COH) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It has been the global leader in implantable hearing solutions for over 40 years, providing a range of implants and sound processor upgrades that deliver a lifetime of hearing outcomes.

COH General Information +

ASX Code COH
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) 8,239
COH Share Price $125.990
Day High $126.470
Day Low $122.240
Last Close $122.000
COH Share Price Movement $3.99 ( 3.27% )
Prices as at 16:40, 6 Aug 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to COH

As a significant Australian company by market capitalisation, COH is held across 35 ETFs spanning strategies that include health care equipment exposure . Its weighting in those funds means performance can have an outsized influence - when COH moves, funds like AQLT, IMPQ, FAIR, MVW and AEAE that hold it can move with it.

For more concentrated exposure, ETFs such as AQLT (BetaShares Australian Quality ETF) allocate about 2.5% to COH , while the average exposure across all 35 ETFs that hold it is around 0.6% .

Top ETF holdings

Last updated: ETF data and holdings as at 6 August 2026

Own COH directly or through an ETF?

How does holding Cochlear Limited (COH) shares directly compare to ETFs that include it?

COH Direct
AQLT
ASX 		IMPQ
ASX 		FAIR
ASX 		MVW
ASX 		AEAE
CBOE
Holdings 1 company 46 holdings 41 holdings 83 holdings 74 holdings 30 holdings
COH Weight 100% 2.5% 2% 1.6% 1.5% 1.3%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only 0.35% p.a. 0.89% p.a. 0.49% p.a. 0.35% p.a. 0.69% p.a.
Approx. Yield - 3.98% 2.03% 2.97% 3.29% -
Star Ratings - starstarstarstar star starstarstarstar starstarstarstar star

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not COH's direct yield. Annual cost uses each ETF's MER.

COH Exposure on $10,000 investment

How a $10,000 investment in Cochlear Limited (COH) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Cochlear Limited (COH) Direct share $125.990 2.85% +$285 $10,285
BetaShares Australian Quality ETF (AQLT) Equity - Australia Strategy $36.160 3.11% +$311 $10,311
eInvest Better Future (Managed Fund) (IMPQ) Equity - Australia Small/Mid Cap $4.440 4.23% +$423 $10,423
BetaShares Australian Sustainability Leaders ETF (FAIR) Equity - Australia Strategy $19.490 2.52% +$252 $10,252
VanEck Australian Equal Weight ETF (MVW) Equity - Australia $39.770 2.11% +$211 $10,211
Australian Ethical High Conviction Fund - Active ETF (AEAE) Equity - Australia Strategy $9.800 3.05% +$305 $10,305

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Cochlear Limited (COH) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result $2.15 85% 19 Mar 2026 13 Apr 2026 - - -
HFResult $2.15 85% 18 Sep 2025 13 Oct 2025 - - -
Result $2.15 80% 20 Mar 2025 14 Apr 2025 - - -

See all dividends from Cochlear Limited (COH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Cochlear Limited (COH) price-sensitive announcements

COH - Trading update and reduction to FY26 earnings guidance
Cochlear Limited has issued a trading update and revised its FY26 earnings guidance downwa
Cochlear Limited (COH)
22 Apr 2026 | 8:20 AM
COH - HY26 Result - Presentation Slides
Cochlear Limited's HY26 Result Presentation highlights financial performance, strategic pr
Cochlear Limited (COH)
13 Feb 2026 | 7:34 AM
COH - HY26 Result - ASX & Media Release
Cochlear Limited reported their financial results for the half-year ending December 2025,
Cochlear Limited (COH)
13 Feb 2026 | 7:33 AM
COH - Appendix 4D and Half Year Financial Report
Cochlear Limited's interim financial report for the half year ended 31 December 2025 shows
Cochlear Limited (COH)
13 Feb 2026 | 7:32 AM

Cochlear Limited (COH) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,240 Becoming a substantial holder 5 Aug 2026 8:20AM $122.320 $125.990 risen by 3%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,240 Notice of FY26 result analyst and media briefing 28 Jul 2026 3:25PM $119.030 $125.990 risen by 5.85%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,240 Becoming a substantial holder 27 Jul 2026 5:43PM $114.500 $125.990 risen by 10.03%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,240 Cochlear statement on US tariff announcement 24 Jul 2026 9:43AM $112.110 $125.990 risen by 12.38%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,240 Notification of cessation of securities - COH 14 Jul 2026 8:27AM $121.300 $125.990 risen by 3.87%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,240 Change in substantial holding 2 Jul 2026 9:18AM $118.450 $125.990 risen by 6.37%

COH Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $462.53 $701.75 10.90% 43.96 490.00 1.59% 100.0%
2025F $417.22 $633.00 7.60% 48.74 440.00 1.43% 100.0%
2024A $386.60 $588.25 27.00% 48.98 410.00 1.42% 75.1%

COH Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
Cochlear Limited (COH) $7,979M 0.0171 -0.1894 0.0615 20.3867 25.1505 23.6925 3.52% 2.84% 2.95%
Fisher & Paykel Healthcare Corporation Limited (FPH) $20,890M 0.1388 0.1458 0.1883 53.7880 46.9447 39.5047 1.22% 1.32% 1.49%
ResMed Inc. (RMD) $18,646M 0.3087 9.7744 0.0595 215.8872 20.0370 18.9119 1.07% 1.12% 1.18%

COH Directors

Name Position Start Date
Ms Christine Frances McLoughlin Non-Executive Director 1 Nov 2020
Sir Michael Grenfell Daniell Non-Executive Director 1 Jan 2020
Ms Karen Lee Collett Penrose Non-Executive Director 1 Jul 2022
Mr Richard John Freudenstein Non-Executive Director 25 Aug 2025
Professor Bruce Gregory Robinson AC Non-Executive Director 13 Dec 2016
Mr Michael del Prado Non-Executive Director 1 Jan 2022
Ms Caroline Louise Clarke Non-Executive Director 2 Sep 2024
Ms Catriona Alison Deans Non-Executive Director, Non-Executive Chairman 1 Jan 2015
Mr Dig Howitt President, Chief Executive Officer, Managing Director 14 Nov 2017

Cochlear Limited (COH) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
19 Feb 2026 ROBINSON AC, Bruce Buy Indirect Shares 253 $198.220 $50,149.660
18 Feb 2026 PENROSE, Karen Buy Indirect Shares 100 $201.220 $20,122.000
16 Feb 2026 FREUDENSTEIN, Richard Buy Indirect Shares 485 $203.609 $98,750.170

See all changes in directors' interest & trades for Cochlear Limited (COH) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

COH Management

Name Position
Dr Sarah Thom Chief Financial Officer
Karen O'Driscoll Chief Information Officer
Jan Janssen Chief Technology Officer
Kristy Jo Company Secretary
Rob McGrory Company Secretary
Rob McGrory Group General Counsel & Company Secretary
Stu Sayers President, Asia Pacific & Latin America
Anthony Bishop President, Europe, Middle East and Africa (EMEA)
Lisa Aubert President, North America
Brian Kaplan Senior Vice President, Global Clinical Strategy and Innovation
Jennifer Hornery Senior Vice President, Global People & Culture
Dean Phizacklea Senior Vice President, Global Strategic Marketing
Greg Bodkin Senior Vice President, Global Supply Chain

COH Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Cochlear Limited (COH). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
4,836,294 (7.40%) State Street Corporation and subsidiaries
4,300,283 (6.60%) BlackRock, Inc
3,756,745 (5.70%) The Vanguard Group,Inc

COH Calendar of Events

Date Event
12 February 2027 Report (Interim)
14 August 2026 Report (Annual)
14 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.